Limited Liability Company (LLC)
Storkpharm
Storkpharm Spółka z Ograniczoną Odpowiedzialnością
Financial results of Storkpharm: revenue, net profit, profitability, ROE, margins, investor ratios and valuation. Data from official KRS filings (0000247708).
Storkpharm has filed financial statements for 8 reporting years in the Polish National Court Register (KRS 0000247708), covering 2018–2025. The dashboard below shows the income statement, balance sheet, profitability ratios, valuation indicators and a multi-year comparison against the company's industry benchmark.
Headline figures for the most recent reported year (2025): net revenue 15,930,659 PLN, net profit 2,248,104 PLN, total assets 14,478,423 PLN and equity -15,888,804 PLN. Use the chart toolbar to switch between absolute amounts and indexed series, or to jump straight into the per-year sprawozdanie finansowe.
Derived metrics include ROE, ROA, net and operating margin, the current ratio and the cash ratio, debt-to-equity and asset turnover. Each ratio is plotted alongside the median for Storkpharm's PKD activity class, so reading whether the company is above or below the industry takes one glance instead of a side-by-side calculation.
Revenue
15.9 M PLN
2025
Net profit
2.2 M PLN
2025
Assets
14.5 M PLN
2025
Equity
-15.9 M PLN
2025
EBITDA
2.5 M PLN
2025
Valuation
8.7 M PLN
Medium confidence
Analysis of financial data across available reporting years
ROA
15.53%
Positive return on assets
Debt ratio
2.10
High leverage
Asset turnover
1.10
Net margin
14.11%
ROE
N/A
Current ratio
1.04
Gross margin
15.73%
Operating margin
15.60%
Debt / equity
N/A
Working capital
522.6 K PLN
8 years of data (2018–2025)
Revenue
2025
Net profit
5/8 profitable years
Assets
2025
Equity
Negative!
Net revenue
Net profit / loss
Profit waterfall 2025
Cost structure 2025
Ratios 2025
Full table of ratios over 8 years (2018–2025)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | -131.50% | -74.78% | -306.23% | 3.07% | 15.73% |
| Operating margin | -131.07% | -74.46% | -304.62% | 3.41% | 15.60% |
| EBIT margin | -131.07% | -74.46% | -304.62% | 3.41% | 15.60% |
| EBITDA margin | -128.84% | -74.12% | -301.60% | 3.47% | 15.71% |
| Net margin | -131.50% | -74.78% | -306.23% | 3.07% | 14.11% |
| ROA | -94.41% | -27.91% | -137.80% | 3.55% | 15.53% |
| Liquidity | |||||
| Current ratio | 0.62 | 0.54 | 0.69 | 0.83 | 1.04 |
| Quick ratio | 0.53 | 0.49 | 0.07 | 0.05 | 0.25 |
| Cash ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.13 |
| Working capital | -8.4 M PLN | -12.7 M PLN | -1.8 M PLN | -1.6 M PLN | 522.6 K PLN |
| Working capital / revenue | -85.66% | -220.69% | -100.23% | -16.80% | 3.28% |
| Leverage | |||||
| Equity ratio | -62.43% | -83.32% | -463.22% | -217.85% | -109.74% |
| Debt / assets | 159.84% | 181.02% | 145.29% | 118.09% | 94.88% |
| Interest coverage (EBIT) | -289.89 | -199.05 | -188.68 | 9.95 | 19413.37 |
| Efficiency | |||||
| Asset turnover | 0.72 | 0.37 | 0.45 | 1.16 | 1.10 |
| Fixed assets / revenue | 2.31% | 3.60% | 4.24% | 1.65% | 1.38% |
| Receivables / revenue | 117.14% | 235.91% | 17.08% | 3.50% | 10.69% |
| DSO (days) | 428 | 861 | 62 | 13 | 39 |
| Inventory days | 63 | 94 | 443 | 301 | 293 |
Estimated value
8.7 M PLN
Range: 2.2 M PLN - 15.5 M PLN
Medium confidence
Input data for 2025, which the model uses to compute the company's estimated value.
Scale of operations
Balance sheet
Debt
Indicators
Limited Liability Company (LLC)
Storkpharm Spółka z Ograniczoną Odpowiedzialnością